Back

Learner’s Digest International (TM)

  • Breast Neoplasms
  • Cardiotoxicity
  • Rhinosinusitis

Acute and Chronic Rhinosinusitis/Cardiotoxicity in Breast Cancer

The goal of this program is to improve management of acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS) and prevention of cardiotoxicity with treatment for breast cancer (BC). After hearing and assimilating this program, the clinician will be better able to: 1. Discern the presentation of ARS and CRS. 2. Weigh efficacy of various nonsurgical treatment modalities for ARS and CRS. 3. Consider surgical procedures to treat CRS refractory to medical therapy. 4. Analyze risks for cardiotoxicity with anthracyclines and antihuman epidermal growth factor receptor-2 therapy for BC. 5. Implement evidence-based recommendations to prevent cardiotoxicity in patients with BC.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

ABIM — Medical KnowledgeUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $1,095

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider · audio-digest.org

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Nov 8, 2026 3 weeks left